Chengwen Li
Principal investigator, leads NABGEN, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$612KFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $612K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 8, 2026 | NIH | STTR Phase I Development of a universal approach to block inhibitors for protein replacement therapy | $312K | NABGEN, INC. |
| Jul 30, 2020 | NIH | STTR Phase I Novel strategy to block AAV neutralizing anitbody activity | $300K | NABGEN, INC. |
Peer ranks
Federal funding#2,166
Awards as PI#1,252
Patents#273
Companies
- NABGEN, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.